{"transactions":[{"id":4640702,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":505,"price":126.5548,"value":63910.174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F18","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.13 to $127.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":132616,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640701,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":597,"price":125.3271,"value":74820.2787,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $124.99 to $125.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":133121,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640700,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":920,"price":124.3652,"value":114415.984,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $123.91 to $124.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":133718,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640699,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":2604,"price":123.2896,"value":321046.1184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $122.903 to $123.8032, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":134638,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640698,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":2072,"price":122.6151,"value":254058.4872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.90 to $122.8795, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":137242,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640697,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-14","kind":"sale","planned":true,"acquired":false,"shares":476,"price":121.1403,"value":57662.7828,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.7075 to $121.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":139314,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640696,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":922,"price":133.7227,"value":123292.3294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.11 to $134.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":139790,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640695,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":579,"price":132.4046,"value":76662.2634,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.07 to $133.045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":140712,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640694,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":1035,"price":131.49,"value":136092.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.07 to $132.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":141291,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640693,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":990,"price":130.4802,"value":129175.398,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.00 to $130.855, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":142326,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640692,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":1644,"price":129.2305,"value":212454.942,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.915 to $129.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":143316,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640691,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":2004,"price":128.5206,"value":257555.2824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.91 to $128.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":144960,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640690,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":817,"price":136.4444,"value":111475.0748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.9387 to $136.8346, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":146964,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640689,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":1447,"price":135.4968,"value":196063.8696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.9283 to $135.8712, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":147781,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640688,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":3335,"price":134.2086,"value":447585.681,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $133.9184 to $134.9182, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":149228,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640687,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":2458,"price":133.2483,"value":327524.3214,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.91 to $133.9078, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":152563,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4640686,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-14T23:14:09.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":5095,"price":132.6165,"value":675681.0675,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $131.91 to $132.9064, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":155021,"source":{"system":"sec-edgar","filing":"0001104659-26-115916","document":"tm2627587-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926115916/tm2627587-1_4seq1.xml","form_type":"4"}},{"id":4618849,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":560,"price":151.3263,"value":84742.728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.16 to $151.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":160116,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618848,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":263,"price":150.4045,"value":39556.3835,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.0525 to $151.0225, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":160676,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618847,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":954,"price":149.3779,"value":142506.5166,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.90 to $149.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":160939,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618846,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":1560,"price":153.099,"value":238834.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.88 to $153.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":161893,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618845,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":6160,"price":152.1159,"value":937033.944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.80 to $152.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":163453,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618844,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":5632,"price":151.4625,"value":853036.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.80 to $151.785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":169613,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618843,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":1274,"price":153.0591,"value":194997.2934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.42 to $153.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":175245,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618842,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":4577,"price":151.7157,"value":694402.7589,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.23 to $152.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":176519,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":4618841,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T01:15:27.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":6520,"price":150.6189,"value":982035.228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Any profit required to be disgorged under Section 16 of the Securities Exchange Act of 1934, as amended, with respect to an aggregate of 445 shares sold in the transactions reported on this Form 4 will be disgorged to the Issuer pursuant to applicable requirements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.23 to $151.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":181096,"source":{"system":"sec-edgar","filing":"0001104659-26-108022","document":"tm2625443-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926108022/tm2625443-1_4seq1.xml","form_type":"4"}},{"id":739522,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:07:12.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest upon the earlier of (i) the first anniversary of the grant date or (ii) the date of the Issuer's next annual meeting of stockholders following the grant date, subject in each case to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":3000,"derivative":{"exercise_price":102.19,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-26-073442","document":"tm2617372-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000110465926073442/tm2617372-5_4seq1.xml","form_type":"4"}},{"id":822706,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T16:05:23.000Z","date":"2026-03-30","kind":"purchase","planned":false,"acquired":true,"shares":445,"price":112.3,"value":49973.5,"ownership":{"direct":true},"balance_after":187616,"source":{"system":"sec-edgar","filing":"0001104659-26-038496","document":"tm2610145-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000110465926038496/tm2610145-3_4seq1.xml","form_type":"4"}},{"id":873821,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-02T08:00:54.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":125,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026."}],"balance_after":187171,"source":{"system":"sec-edgar","filing":"0001104659-26-021922","document":"tm267613-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000110465926021922/tm267613-2_4seq1.xml","form_type":"4"}},{"id":1114769,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-11T19:59:46.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12350,"derivative":{"exercise_price":26.23,"exercise_date":"2026-06-10","expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001583648-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000158364825000040/edgardoc.xml","form_type":"4"}},{"id":1173890,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-10T19:06:12.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":2490,"price":20.27,"value":50472.3,"ownership":{"direct":false,"nature":"by foundation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Eagles Mere Air Museum Foundation"}],"balance_after":13516,"source":{"system":"sec-edgar","filing":"0001583648-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000158364825000025/edgardoc.xml","form_type":"4"}},{"id":1173889,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-10T19:06:12.000Z","date":"2025-04-09","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":20.13,"value":50325.0,"ownership":{"direct":true},"balance_after":183171,"source":{"system":"sec-edgar","filing":"0001583648-25-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000158364825000025/edgardoc.xml","form_type":"4"}},{"id":1325235,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T10:23:28.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":12.93,"value":51720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.59 to $13.09, inclusive. The reporting person undertakes to provide to Palvella Therapeutics, Inc., any security holder of Palvella Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":180671,"source":{"system":"sec-edgar","filing":"0001062993-24-020879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000106299324020879/form4.xml","form_type":"4"}},{"id":1328392,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":38659,"kind":"person","name":"JENKINS GEORGE M","position":1,"cik":"0001271081","reported_name":"JENKINS GEORGE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-17T20:42:28.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":24700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest and become exercisable in 36 equal monthly installments through the third anniversary of the grant date."}],"balance_after":24700,"derivative":{"exercise_price":13.6,"expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":24700},"source":{"system":"sec-edgar","filing":"0001062993-24-020817","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271081/000106299324020817/form4.xml","form_type":"4"}}]}